Abstract
BackgroundGlioblastoma (GBM) is the most common primary malignant brain tumor and shows poor outcomes, with a median survival of 12–18 months using the current standard-of-care therapy. GBM exhibits sex differences...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
